WaveMan · Form 4
Patel Sanjiv insider trades
> Search tickers & screens ⌘K
LIVE

Patel Sanjiv insider trades

Patel Sanjiv has filed 28 Form 4s with the SEC that we hold, for Relay Therapeutics, Inc. (RLAY) (President and CEO, Director) and Prothena Corp Public LTD Co (PRTA) (Director). Across all of them we count 0 purchases worth $0 and 37 sales worth $16.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 6 sales ($4.5M). The largest single trade was a sale of 48,199 shares of Relay Therapeutics, Inc. worth $979.9K, dated 2026-08-17. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-01-07 and the latest 2026-10-08.

Relay Therapeutics, Inc. (RLAY)

President and CEO, Director · 28 filings · 37 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-04-12S, sale reported on Form 428,000$890.4K2022-04-14
2022-04-13S, sale reported on Form 414,000$447.2K2022-04-14
2022-04-13S, sale reported on Form 414,000$447.4K2022-04-14
2022-04-14S, sale reported on Form 414,000$427.1K2022-04-14
2022-09-13S, sale reported on Form 414,000$356.3K2022-09-15
2022-09-14S, sale reported on Form 414,000$328.6K2022-09-15
2022-09-15S, sale reported on Form 414,000$333.2K2022-09-15
2022-10-11S, sale reported on Form 414,000$299.0K2022-10-13
2022-10-12S, sale reported on Form 414,000$296.5K2022-10-13
2022-10-13S, sale reported on Form 414,000$288.1K2022-10-13
2022-11-08S, sale reported on Form 414,000$282.5K2022-11-10
2022-11-10S, sale reported on Form 418,175$363.5K2022-11-10
2022-11-10S, sale reported on Form 49,825$196.5K2022-11-10
2023-01-17S, sale reported on Form 428,000$566.4K2023-01-19
2023-01-18S, sale reported on Form 428,000$584.4K2023-01-19
2023-01-19S, sale reported on Form 428,000$560.6K2023-01-19
2023-02-07S, sale reported on Form 414,000$300.3K2023-02-09
2023-02-08S, sale reported on Form 414,000$293.7K2023-02-09
2023-02-09S, sale reported on Form 414,000$287.7K2023-02-09
2024-07-25S, sale reported on Form 450,000$458.0K2024-07-29
2024-07-26S, sale reported on Form 436,706$332.9K2024-07-29
2024-12-16S, sale reported on Form 4100,000$500.0K2024-12-18
2025-01-21S, sale reported on Form 4125,000$565.0K2025-01-23
2025-01-22S, sale reported on Form 4125,000$600.0K2025-01-23
2025-01-23S, sale reported on Form 4125,000$597.5K2025-01-23
2025-02-11S, sale reported on Form 4140,182$539.7K2025-02-13
2025-02-13S, sale reported on Form 475,324$278.7K2025-02-13
2025-04-23S, sale reported on Form 418,653$55.4K2025-04-24
2025-04-23S, sale reported on Form 442,769$127.0K2025-04-24
2025-07-09S, sale reported on Form 418,639$66.5K2025-07-10
2025-07-09S, sale reported on Form 442,740$152.6K2025-07-10
2025-11-03S, sale reported on Form 462,073$434.5K2025-11-04
2026-01-06S, sale reported on Form 443,168$337.6K2026-01-07
2026-07-07S, sale reported on Form 448,199$943.7K2026-07-08
2026-08-17S, sale reported on Form 448,199$979.9K2026-08-18
2026-09-08S, sale reported on Form 448,199$912.9K2026-09-09
2026-10-07S, sale reported on Form 448,199$872.4K2026-10-08

Prothena Corp Public LTD Co (PRTA)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1816210) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms